Print

Please select the PCN:

 

Anticoagulant Indicators

 

Indicator IP6

Multiple prescribing of anticoagulants and antiplatelet medicine (p-chart)

Sorry, chart data coming soon

 

More information about this indicator

Definition: Patients (all, 65 and over, 75 and over, 85 and over) prescribed three or more unique medicines that have an anticoagulant or antiplatelet action as a percentage of patients prescribed one or more unique medicines that have an anticoagulant or antiplatelet action during the same reporting period.

Numerator: Number of patients (all, 65 and over, 75 and over, 85 and over) prescribed three or more unique medicines within a single month that have an anticoagulant or antiplatelet action and are included in one or more of the following BNF codes:

BNF Name: Oral Anticoagulants BNF Code: 0208020

Excluding INR Blood Testing Reagents BNF Code: 0208020W0

BNF Name: Antiplatelet Drugs BNF Code: 0209000

Only aspirin 75mg presentations (BNF 2.9) are included in the numerator (BNF 209000). Whilst prescribers should be aware that other aspirin containing presentations (BNF 4.7.1 which includes aspirin 300mg) and Non-Steroidal Anti-inflammatory Drugs exert antiplatelet activity, they have been excluded from the numerator. These prescribing comparators should be viewed as developmental and the specifications will be reviewed over time.

Parenteral anticoagulants have also been excluded on the basis that they may be prescribed prior to commencing oral treatment and potentially captured in the same reporting period.

Denominator: Number of patients (all, 65 and over, 75 and over, 85 and over) prescribed one or more medicines that have an anticoagulant or antiplatelet action within same BNF areas as numerator during same time period as numerator.

Methodology: Numerator divided by denominator. Presented as a percentage

Please follow this link for a detailed technical specification ( on page 12 and 13 of this publication prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator S2

GIB02:[Increased risk of hospital admission] Prescribed NSAID + oral anticoagulant (i-chart)

This indicator is not available at PCN level. Please visit CCG, STP or AHSN pages to view data relating to this indicator.

 

More information about this indicator

Title: GIB02 Patients aged 18 or over currently prescribed a non-steroidal anti-inflammatory drug (NSAID) and concurrently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant (DOAC)) and therefore potentially at increased risk of admission to hospital with a GI bleed

Definition: Number of patients aged 18 or over in the month of prescription currently prescribed a non-steroidal anti-inflammatory drug (NSAID) and concurrently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant (DOAC)) per 10,000 patients currently prescribed a NSAID or an oral anticoagulant.

Numerator: Patients aged 18 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) and concurrently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant) (DOAC)).

Denominator: Patients aged 18 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) or an oral anticoagulant (warfarin or a direct oral anticoagulant) (DOAC)).

Methodology: Numerator divided by denominator, presented per 10,000 patients.

Purpose: The purpose of the indicator is to quantify the number of patients taking a non-steroidal anti-inflammatory drug (NSAID) and concurrently taking an oral anticoagulant (warfarin or a direct oral anticoagulant) (DOAC)), and therefore potentially having an increased risk of a GI bleed, presented as a proportion (per 10,000) of patients taking a NSAID or an oral anticoagulant.

Reporting Level: Quarterly aggregate results at National, Regional and CCG level>

A detailed technical specification for this indicator is available from page 15 - 17 of this publication (prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

Indicator S3

GIB03:[Increased risk of hospital admission] Prescribed an oral anticoagulant + anti-platelet without gastro-protection (i-chart)

This indicator is not available at PCN level. Please visit CCG, STP or AHSN pages to view data relating to this indicator.

 

More information about this indicator

Title: Patients aged 18 or over currently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant (DOAC)) with an anti-platelet and not concurrently prescribed a gastro-protective medicine and therefore potentially at increased risk of admission to hospital with a GI bleed.

Definition: Number of patients aged 18 or over in the month of prescription currently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant (NOAC)) with an anti-platelet and not concurrently prescribed a gastro-protective medicine per 10,000 patients currently prescribed an oral anticoagulant with an anti-platelet (with or without a gastro-protective medicine)

Numerator: Patients aged 18 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) and concurrently prescribed an oral anticoagulant (warfarin or a direct oral anticoagulant) (DOAC)).

Denominator: Patients aged 18 or over in the prescription month prescribed a nonsteroidal anti-inflammatory drug (NSAID) or an oral anticoagulant (warfarin or a direct oral anticoagulant) (DOAC)).

Methodology: Numerator divided by denominator, presented per 10,000 patients

Purpose: The purpose of the indicator is to quantify the number of patients taking an oral anticoagulant (warfarin or a direct oral anticoagulant (DOAC)) with an anti-platelet and not concurrently taking a gastro-protective medicine (and therefore potentially having an increased risk of a GI bleed), presented as a proportion (per 10,000) of patients taking an oral anticoagulant with an anti-platelet (with or without a gastro-protective medicine)

A detailed technical specification for this indicator is available from page 15 - 17 of this publication (prepared by NHS BSA)

Data for this indicator has been sourced from the ePACT2 data warehouse. Click here to login to ePACT2.

 

NB: Low volume figures have not been redacted and therefore individual patients may be identifiable. Please take care when disseminating data and contact your Caldicott Guardian for further guidance.

Hits: 153